➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Colorcon
Johnson and Johnson
AstraZeneca
Mallinckrodt

Last Updated: October 28, 2021

DrugPatentWatch Database Preview

Litigation Details for Belcher Pharmaceuticals, LLC v. Hospira, Inc. (D. Del. 2017)


Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in Belcher Pharmaceuticals, LLC v. Hospira, Inc.
The small molecule drug covered by the patents cited in this case is ⤷  Free Forever Trial .
Biologic Drugs cited in Belcher Pharmaceuticals, LLC v. Hospira, Inc.
The biologic drug covered by the patents cited in this case is ⤷  Free Forever Trial .

Details for Belcher Pharmaceuticals, LLC v. Hospira, Inc. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
2018-12-13 118 Notice of Service 's Invalidity Contentions Regarding U.S. Patent No. 9,283,197 filed by Hospira, Inc..(Haney, Megan) (Entered…2017 20 April 2020 1:17-cv-00775 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2019-01-06 123 Transcript Pharmaceuticals LLC v Hospira Inc., Civil Action No. 10 17-775-LPS. And we set this time to talk about …that he is a manager of patent litigation, patent 3 enforcement, patent prosecution, a whole number… to manage 3 Hospira's portfolio of patent litigation. He supervises and 4 …. He is not involved with 22 the patent prosecution. 23 And on these…Belcher has 15 with third parties about the patent. 16 Communications with the External link to document
2020-03-31 244 Opinion bioequivalent product infringes U.S. Patent No. 9,283,197 (“the ’197 Patent”) under the doctrine of equivalents…that it does not infringe the ’197 Patent and, further, that the Patent is invalid and/or unenforceable… infringe the ’197 Patent under the doctrine of equivalents, (2) the ’197 Patent is invalid as obvious…D.I. 201 at ¶¶ 3-5) II. Patent-in-Suit 8. The ’197 Patent, entitled “More Potent and …a named inventor on more than 39 U.S. patents, including patents related to drug development, formulation External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Medtronic
Boehringer Ingelheim
Merck
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.